Hikma Pharmaceutical reported $256M in Selling and Administration Expenses for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
AstraZeneca AZN:LN USD 3.35B 280M
Bayer BAYN:GR EUR 4.08B 393M
Fresenius FRE:GR EUR 1.61B 21M
Fresenius Medical Care FMS:US EUR 989.61M 20.12M
Galapagos GLPG:NA EUR 55.51M 16.16M
Genmab GEN:DC DKK 670M 37M
GlaxoSmithKline GSK:LN GBP 1.97B 13M
Hikma Pharmaceutical HIK:LN USD 256M 0
Merck MRK:GR EUR 1.55B 26M
Orion ORNBV:FH EUR 76.2M 11.5M
Recordati REC:IM EUR 144.95M 131K